Healthcare -
Biotechnology - NASDAQ - US
$ 5.17
2.64 %
$ 461 M
Market Cap
-1.63
P/E
AMLX - NET INCOME
Net Income AMLX - Amylyx Pharmaceuticals, Inc.
-302 M
LAST VALUE
-23.33%
2 YEAR CAGR
-85.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR